Kodiak Sciences Inc. K27.F Stock
Kodiak Sciences Inc. Price Chart
Kodiak Sciences Inc. K27.F Financial and Trading Overview
| Kodiak Sciences Inc. stock price | 3.39 EUR |
| Previous Close | 8.16 EUR |
| Open | 8.27 EUR |
| Bid | 8.27 EUR x N/A |
| Ask | 8.56 EUR x N/A |
| Day's Range | 8.27 - 8.27 EUR |
| 52 Week Range | 3.84 - 13 EUR |
| Volume | 50 EUR |
| Avg. Volume | 21 EUR |
| Market Cap | 432.88M EUR |
| Beta (5Y Monthly) | 1.744013 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.56 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 121.55 EUR |
K27.F Valuation Measures
| Enterprise Value | 116.33M EUR |
| Trailing P/E | N/A |
| Forward P/E | -1.375707 |
| PEG Ratio (5 yr expected) | -1.67 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.0964063 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.372 |
Trading Information
Kodiak Sciences Inc. Stock Price History
| Beta (5Y Monthly) | 1.744013 |
| 52-Week Change | 32.15% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 13 EUR |
| 52 Week Low | 3.84 EUR |
| 50-Day Moving Average | 5.08 EUR |
| 200-Day Moving Average | 6.69 EUR |
K27.F Share Statistics
| Avg. Volume (3 month) | 21 EUR |
| Avg. Daily Volume (10-Days) | 45 EUR |
| Shares Outstanding | 52.36M |
| Float | 31.8M |
| Short Ratio | N/A |
| % Held by Insiders | 5.69% |
| % Held by Institutions | 80.45% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -26.85% |
| Return on Equity (ttm) | -62.40% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -312919008 EUR |
| Net Income Avi to Common (ttm) | -308894016 EUR |
| Diluted EPS (ttm) | -5.95 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 421.19M EUR |
| Total Cash Per Share (mrq) | 8.09 EUR |
| Total Debt (mrq) | 86.75M EUR |
| Total Debt/Equity (mrq) | 22.1 EUR |
| Current Ratio (mrq) | 6.254 |
| Book Value Per Share (mrq) | 7.541 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -210520000 EUR |
| Levered Free Cash Flow (ttm) | -132880496 EUR |
Profile of Kodiak Sciences Inc.
| Country | Germany |
| State | CA |
| City | Palo Alto |
| Address | 1200 Page Mill Road |
| ZIP | 94304 |
| Phone | (650) 281-0850 |
| Website | https://kodiak.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 115 |
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Q&A For Kodiak Sciences Inc. Stock
What is a current K27.F stock price?
Kodiak Sciences Inc. K27.F stock price today per share is 3.39 EUR.
How to purchase Kodiak Sciences Inc. stock?
You can buy K27.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kodiak Sciences Inc.?
The stock symbol or ticker of Kodiak Sciences Inc. is K27.F.
Which industry does the Kodiak Sciences Inc. company belong to?
The Kodiak Sciences Inc. industry is Biotechnology.
How many shares does Kodiak Sciences Inc. have in circulation?
The max supply of Kodiak Sciences Inc. shares is 53.29M.
What is Kodiak Sciences Inc. Price to Earnings Ratio (PE Ratio)?
Kodiak Sciences Inc. PE Ratio is now.
What was Kodiak Sciences Inc. earnings per share over the trailing 12 months (TTM)?
Kodiak Sciences Inc. EPS is -4.56 EUR over the trailing 12 months.
Which sector does the Kodiak Sciences Inc. company belong to?
The Kodiak Sciences Inc. sector is Healthcare.